{
    "title": "U.S. FDA extends review of Bristol Myers' cancer therapy acquired in Celgene deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8292695/U-S-FDA-extends-review-Bristol-Myers-cancer-therapy-acquired-Celgene-deal.html",
    "date": "2020-05-06",
    "keywords": [
        "therapy",
        "drug",
        "cancer",
        "information",
        "agency",
        "part",
        "buyout",
        "celgene",
        "patient",
        "wednesday",
        "regulator",
        "review",
        "blood",
        "drugmaker",
        "company",
        "amendment",
        "marketing",
        "application",
        "food",
        "administration",
        "bristol",
        "decision",
        "lisocel",
        "corp",
        "agreement",
        "contingent",
        "value",
        "payment",
        "share",
        "development",
        "bcell",
        "lymphoma",
        "class",
        "cart",
        "cell",
        "treatment",
        "reporting",
        "sibi",
        "joseph",
        "bengaluru",
        "editing",
        "daniel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}